首页> 外文期刊>Pediatric Research >Pharmacokinetic Studies with a Long-Acting sulfnamide in Subjects of Different Ages: A Modern Approach to Drug Dosage Problems in Developmental Pharmacology
【24h】

Pharmacokinetic Studies with a Long-Acting sulfnamide in Subjects of Different Ages: A Modern Approach to Drug Dosage Problems in Developmental Pharmacology

机译:长效磺酰胺在不同年龄受试者中的药代动力学研究:发展药理学中药物剂量问题的现代方法

获取原文
           

摘要

Extract: The principle aims of this paper are to discus the stiking differences in sulfonamides pharmacokinetics which can be observed when compaing groups of subjects at very different stages of development and to demonstrate the practical value of investigations to establish the correct dosage of a drug in infants and children. The sulfonamide compound used for this study was 2-sulfa-3-methoxy-pyrazine.The first series of investigations concerned the determination of all the biological constants needed to establish the optimal dosage of the drug for five groups: newborns, infants, children, adults and elderly subjects. The vlues measured included protein-binding and pharmacokinetic constants. The second series of studies investigated the application of the Krüger-Thiemer pharmacokinetic theory in the five age groups.When compared with adult values, the drug concentration in plasma water at half saturation binding is higher in newborn and elderly subjects, while it is rathere low in children (table II). The maximum binding capacity of the plasma did not differ in a signifiacant way among all groups studied, with the exception of the elderly subjects in whom high vlaues were found. As a result of the relatively marked changes with age of these two constants, the minimum concentration of free sulfonamide in plasma was found to be much higher in newborns than in all other groups.In table III, pharmacokinetic constants are reported. The rate constant of absorption was found to decrease from high values in newborns and in infants to low values in children; the lowest values were found in adults, whereas in elderly subjects the constant was again high. The rate constant of elimination was very low in newborns, higher in infants and children, slightly lowere in adults and was very low again in elderly subjects. As was expected, an inverse trend was observed when the time of half elimination (biological half-life) was calculated, being highest in newborns, lower and approximately equal in infants, children and adults and very significantly eleveted in elderly subjects. The coefficient of distribution fo 2-sulfa-3-methoxy-pyrazine was found to be very high in newborns, high in infants, low and about equal in children and adults and again high in elderly subjects.When the theoretical maintenance dose and the ratio between initial and maintenance dose were calculated from the pharmacokinetic constants and from the protein-binding constants, values characteristic of each state of development were obtained (tables III and IV). Relative maintenance dose was found to be very low in newborns, high in infants and children and lower in adults and elderly subjects. The initial to maintenance dose ratio was found, on the contrary, to be very high in newborns and elderly subjects and about equal in infants, children and adults, the children showing the lowest values.The practical value of the Krüger-Thiemer method for calculating an optimal dosage regimen was tested by measuring plasma concerntrations of sulfonamide in subjects of different ages treated for prolonged periods of time. A remarkably constant minimum blood concernation was found in each instance, thus indicating that the theoretic treatment of the variables had permitteed prediction of optimal drug dosage (figs. 4 and 5).Specultion: The Krüger-Thiemer method was found very useful to calculate the optimal drug dosage regimen in subjects of different ages, from birth through senescence. This same type of experimental approach could be used in the future, with profit, to calculate optimal dosages of other drugs for which the therapeutic effect depents chiefly upon the maintenance of a relatively constant plasma concentration.
机译:摘录:本文的主要目的是探讨磺胺类药代动力学的刺激性差异,当在不同发育阶段的受试者组进行比较时,可以观察到这些差异,并证明确定婴儿正确剂量药物的研究的实际价值。和孩子们。本研究中使用的磺酰胺化合物为2-磺胺基-3-甲氧基-吡嗪。第一系列研究涉及确定为五组药物(新生儿,婴儿,儿童,成人和老年人。测得的糊包括蛋白质结合常数和药代动力学常数。第二系列研究探讨了克鲁格-蒂默(Krüger-Thiemer)药代动力学理论在五个年龄组中的应用。与成人相比,新生儿和老年人中半饱和结合时血浆水中的药物浓度较高,而较低在儿童中(表二)。在所有研究组中,血浆的最大结合能力没有显着差异,除了老年患者中发现高血管。由于这两个常数随年龄的变化相对明显,新生儿血浆中游离磺酰胺的最低浓度比所有其他组均高得多。表III中报告了药代动力学常数。发现吸收速率常数从新生儿和婴儿的高值降低到儿童的低值;在成年人中发现最低值,而在老年受试者中,常数再次很高。新生儿的消除率常数非常低,婴儿和儿童的消除率常数很高,成人的消除率常数稍低,而老年受试者的消除率常数也很低。如预期的那样,计算半消除时间(生物学半衰期)时观察到相反的趋势,在新生儿中最高,在婴儿,儿童和成人中较低,大约相等,在老年受试者中非常明显。在新生儿中,2-磺基-3-甲氧基-吡嗪的分布系数非常高,婴儿较高,儿童和成人较低,大约相等,老年受试者中较高,当理论维持剂量和比例根据药代动力学常数和蛋白质结合常数计算初始剂量和维持剂量之间的差,获得每种发育状态的特征值(表III和IV)。发现新生儿的相对维持剂量非常低,婴儿和儿童较高,而成人和老年人则较低。相反,新生儿和老年受试者的初始剂量与维持剂量之比很高,而婴儿,儿童和成人的初始剂量与维持剂量之比相当,儿童的数值最低.Krüger-Thiemer方法的实用价值通过测量长期治疗的不同年龄受试者的磺酰胺血浆相关性,测试了最佳剂量方案。在每种情况下都发现了一个非常恒定的最低血液关注度,因此表明该变量的理论处理可以预测最佳药物剂量(图4和5)。推测:发现Krüger-Thiemer方法对计算最佳药物剂量非常有用。从出生到衰老的不同年龄受试者的最佳药物剂量方案。将来,可以利用这种相同类型的实验方法来盈利,以计算其他药物的最佳剂量,这些药物的治疗效果主要取决于维持相对恒定的血浆浓度。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号